Microbial genomics is a transformative field that reveals the entire genetic content of microorganisms (bacteria, archaea, viruses, and single-cell eukaryotes) in order to understand and predict their biology, pathogenicity, resistance, and interactions with hosts and the environment. Sequencing technologies (Illumina, Oxford Nanopore, and PacBio) have significantly contributed to high-resolution analyses via whole genome sequencing (WGS), metagenomics, and functional genomics. Such tools have drastically increased our capacity to track infectious disease outbreaks, antimicrobial resistance (AMR), and microbiome dynamics. The importance of microbial genomics in health applications. Precision diagnostics, therapeutic protein engineering, vaccine development, and real-time pathogen surveillance during the COVID-19 pandemic are underpinned by microbial genomics in healthcare. It also helps to understand the microbiota gut–brain axis, autoimmune diseases, and metabolic disorders through the study of host–microbe relations using multi-omics technologies. In Bangladesh, genomic analysis has detected resistant pathogens, facilitated outbreak investigations, and guided local stewardship policies. However, the obstacles of poor infrastructure, low bioinformatics capability, high expense, and poor regulatory environments still retard the popularization of NGS. The future growth will need holistic national plans, including genomic literacy, data governance, and infrastructure scaling. Indeed, microbial genomics is a frontier in contemporary science and medicine, promising evidence-based strategies for public health, biotechnology, and personalized medicine—particularly, in low- and middle-income countries ready for transformation, like Bangladesh.